NCT04206904

Brief Summary

In the first part of this study the prevalence of frailty in patients with cardiovascular disease will be examined. Frailty is defined as a progressive age-related decline in physiological systems that results in decreased reserves of intrinsic capacity, which confers extreme vulnerability to stressors. Patients (≥65 years, men and women) suffering from heart failure or undergoing a coronary artery bypass grafing (CABG) or percutaneous coronary intervention (PCI) will be included. Based on the phenotype of Fried, frailty will be examined in the physical domain. Moreover, the nutritional, social, psychological and cognitive domain of frailty will be examined. This will result in a total score of 0 (no frailty) to 24 (severe frailty), divided into four categories: no frailty (score 0-6), minor frailty (score 7-12), moderate frailty (score 13-18) or severe frailty (score 18-24). Besides this frailty protocol, a few other measurements will be completed to collect additional information about the functioning of the patient. At discharge from the hospital, some of these patients will start with a cardiac rehabilitation program. To define the exercise intensity of this program, patients will perform a maximal exercise test (CPET). In the second part of this study, correlations will be examined between markers of frailty and markers of exercise from the CPET (e.g. maximal heart rate, maximal oxygen uptake).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 25, 2019

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

December 17, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 20, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2020

Completed
Last Updated

June 24, 2020

Status Verified

June 1, 2020

Enrollment Period

7 months

First QC Date

December 17, 2019

Last Update Submit

June 23, 2020

Conditions

Keywords

older adultscardiovascular diseasesmaximal exercise test

Outcome Measures

Primary Outcomes (13)

  • Level of (in)dependence via the Katz scale

    Evaluation of the level of (in)dependence in activities of daily life via a 4-point scale (1-4)

    At baseline

  • Nutritional status via the Mini Nutritional Assessment (MNA)

    Examination of the nutritional status of the patient via a questionnaire (30 points)

    At baseline

  • Level of physical activity via the International Physical Activity Questionnaire (IPAQ)

    Examination of the level of physical activity of the patient via a questionnaire

    At baseline

  • Cognitive status via the Mini Mental State Examination (MMSE)

    Examination of the cognitive status of the patient via a short screening (30 points)

    At baseline

  • Psychological status via the Geriatric Depression Scale (GDS-15)

    Examination of the presence/absence of a depressive mood via a questionnaire (15 questions/15 points)

    At baseline

  • Concern about falling via the Falls Efficacy Scale (FES-I)

    Examination of the level of concern about falling during social and physical activities via a questionnaire (16 questions/ 64 points)

    At baseline

  • Weight loss via the evaluation of body weight

    Evaluation of involuntary loss of body weight in the previous months

    At baseline

  • Gait speed via the 4.6 meter walking test

    Examination of the walking speed of the patient

    At baseline

  • Evaluation of handgrip strength

    Evaluation of the handgrip strength of the patient via handheld dynamometry

    At baseline

  • Examination of mobility/balance/muscle strength/risk of falling via the Timed Up and Go Test (TUG)

    The Timed Up and Go Test measures the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down. By combining this test with a motor or cognitive dual task, the risk of falling of the patient will be examined.

    At baseline

  • Comorbidities via the record of medication use

    Record of cardiac and other medications

    At baseline

  • Evaluation of lower limb strength

    Evaluation of lower limb strength of the patient via Microfet measurements

    At baseline

  • Evaluation of functional lower limb strength

    Evaluation of functional lower limb strength of the patient via the Timed Chair Stand Test

    At baseline

Secondary Outcomes (1)

  • Correlations between frailty (via the primary frailty outcome measures) and exercise parameters (via the maximal exercise test (CPET)

    At the start of the cardiac rehabilitation program

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Men and women with an age of at least 65 years at the start of the study who are admitted to Jessa Hospital Hasselt because of suffering from coronary artery diseases (with planned PCI or CABG surgery) or heart failure

You may qualify if:

  • Men and women with an age of at least 65 years at the start of the study; Staying in Jessa Hospital for PCI, CABG or heart failure

You may not qualify if:

  • A persistently unstable clinical condition at baseline visit (angina, advanced conduction disturbances, threatening ventricular arrhythmias, acute heart failure, clinical condition requiring interventions such as acute renal failure, Hb \<9,0 mg/dl, presence of end-stage disease or the lack of informed consent to study participation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jessa Hospital Campus Virga Jesse

Hasselt, Limburg, 3500, Belgium

Location

MeSH Terms

Conditions

FrailtyCardiovascular Diseases

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Invesigator

Study Record Dates

First Submitted

December 17, 2019

First Posted

December 20, 2019

Study Start

November 25, 2019

Primary Completion

June 23, 2020

Study Completion

June 23, 2020

Last Updated

June 24, 2020

Record last verified: 2020-06

Locations